TGFB1 and neoplasm: More recent literature has reported that activation of EMT- and TGFb-related pathways could impede lymphocyte infiltration into tumor parenchyma (51), and it has been proposed that targeting specific molecular inhibitors of TGFb could remodel the tumor microenvironment and reinstate antitumor immunity (35, 52).